Vlad Tenev has a message for Wall Street professionals confounded by the everyday investors who have become a driving force ...

Nike Inc. has endured a tough few years marked by weaker demand and its own struggles to adapt to shifting trends. While the ...

Weaker-than-expected spending figures are having more of an impact on the Treasury market Friday morning than a slightly hotter-than-expected core inflation reading as investors parse May personal ...

Progress on the U.S. trade front and weaker economic data bolster the case for a September rate cut by the Federal Reserve, according to Thierry Wizman, global foreign-exchange and rates strategist at ...

Americans cut spending in May after buying lots of new cars and other goods earlier in the year to beat U.S. tariffs, ...

Treasury yields ticked lower in recent trade on Friday after the latest reading on U.S. personal income and spending came in weaker than economists had expected, while a gauge of core prices rose by ...

The latest PCE report probably cements the status quo. Investors expect the Fed to wait until September to cut interest rates ...

To be specific, Grossman, a 49-year-old entrepreneur who calls suburban New York City home, has about 45 credit cards.

A.P. Moller-Maersk resumed vessel calls to the port of Haifa in Israel and will accept both import and export cargo following a de-escalation of tensions in the region. The Danish shipping and ...

President Donald Trump said Thursday that a deal had been signed “yesterday” with China, but offered no details.

Schrodinger has won U.S. Food and Drug Administration fast-track designation for its SGR-1505 drug candidate in a rare type of non-Hodgkin's lymphoma.

Ultragenyx Pharmaceutical received breakthrough therapy designation from the U.S. Food and Drug Administration for its drug GTX-102, which is designed to treat people with Angelman syndrome. Angelman ...